Related Experiment Video
Updated: Jun 3, 2026

Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
Neurological manifestations of atrio-esophageal fistulas from left atrial ablation
J Finsterer1, C Stöllberger, T Pulgram
1Krankenanstalt Rudolfstiftung, Vienna, Austria. fifigs1@yahoo.de
Insights
Atrio-esophageal fistula (AEF) is a rare but serious complication following left atrial ablation (LAAB). Neurological symptoms like stroke are common, and surgical closure offers a poor prognosis.
Area of Science:
- Cardiology
- Neurology
- Gastroenterology
Background:
- Left atrial ablation (LAAB) treats refractory atrial fibrillation.
- Atrio-esophageal fistula (AEF) is an emerging complication of LAAB.
Observation:
- AEF presents with neurological symptoms due to embolism (thrombi, esophageal contents, air).
- Reported in 52 patients across 24 publications, manifesting 17 days post-ablation.
- Neurological signs include stroke, seizures, TIA, coma, and psychiatric issues.
Findings:
- Cerebral imaging often reveals embolic strokes or air embolism.
- Diagnosis confirmed by thoracic CT with contrast; avoid swallowing, TEE, gastroscopy, or stenting.
- Surgical closure is the only treatment, but mortality remains high at 71%.
Implications:
- Suspect AEF in LAAB patients with neurological symptoms (fever, pain, stroke, seizures, coma) 3-5 weeks post-ablation.
- Diagnostic workup must prevent fistula enlargement.
- Urgent surgical intervention is critical despite poor outcomes.
Abstract:
Left atrial ablation (LAAB) is carried out as an alternative treatment of atrial fibrillation refractory to conservative measures. An increasingly recognized complication of LAAB is an atrio-esophageal fistula (AEF). Neurological manifestations usually dominate the presentation of an AEF and result from cardiac embolism of thrombi, transgressed esophageal contents, or air. AEFs have been reported after LAAB in 52 patients (23 men, age 35-76 years), described in 24 publications, so far. AEFs manifest clinically on the average 17 days (3-38 days) after ablation. Neurological manifestations include embolic strokes (n = 30), seizures (n = 9), transitory-ischaemic attacks (n = 6), coma (n = 6), or psychiatric abnormalities (n = 5). Imaging studies of the cerebrum most frequently show multiple embolic strokes or air embolism. The diagnosis is made upon thoracic computed tomography with contrast media. An act of swallowing, trans-esophageal echocardiography, gastroscopy, or esophageal stenting must be avoided not to enlarge the shunt. The only expedient therapy is surgical closure of the fistula, but even then, the prognosis is poor with a mortality of 71%. AEFs should be suspected if there is a history of LAAB followed by fever, thoracic pain, postprandial cerebral strokes, seizures, coma, or confusion with a latency of days to 5 weeks after ablation. Diagnostic work-up must avoid measures, which enlarge the fistula. Treatment is surgical exclusively.
Related Concept Videos
Esophageal Achalasia
Heart Failure III: Clinical Manifestations
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

